STOKE THERAPEUTICS INC shareholders Q3 2023

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TWO SIGMA ADVISERS, LP 13,800$54,3720.00%
Daiwa Securities Group Inc. 126$00.00%
SIMPLEX TRADING, LLC 2,681$100.00%
Citadel Advisors 4,400$17,3360.00%
MetLife Investment Management, LLC 14,616$57,5870.00%
Tower Research Capital LLC (TRC) 3,741$14,7390.00%
Cutler Group LLC / CA 500$10.00%
Cutler Group LLC / CA 600$20.00%
Allspring Global Investments Holdings, LLC 14,790$58,2720.00%
Beaird Harris Wealth Management, LLC 38$1500.00%
JPMORGAN CHASE & CO 26,530$104,5280.00%
BARCLAYS PLC 8,440$330.00%
ROYAL BANK OF CANADA 4,632$18,0000.00%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 16,335$64,0000.00%
VANGUARD GROUP INC 1,630,688$6,424,9120.00%
Swiss National Bank 43,300$170,6020.00%
GREAT WEST LIFE ASSURANCE CO /CAN/ 2,968$120.00%
Ameritas Investment Partners, Inc. 2,278$8,9750.00%
FEDERATED HERMES, INC. 1,076$4,2390.00%
VOYA INVESTMENT MANAGEMENT LLC 11,175$44,0300.00%
External links

This page lists STOKE THERAPEUTICS INC's shareholders in Q3 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.